Patterson Companies, Inc. PDCO
We take great care to ensure that the data presented and summarized in this overview for PATTERSON COMPANIES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PDCO
View all-
Black Rock Inc. New York, NY12.9MShares$404 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.41MShares$295 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.53MShares$111 Million0.03% of portfolio
-
State Street Corp Boston, MA3.33MShares$104 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.71MShares$84.9 Million0.05% of portfolio
-
Morgan Stanley New York, NY2.17MShares$67.9 Million0.0% of portfolio
-
Equity Investment Corp Atlanta, GA2.03MShares$63.6 Million1.56% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$58.9 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA1.8MShares$56.4 Million0.01% of portfolio
-
Allspring Global Investments Holdings, LLC1.69MShares$52.8 Million0.09% of portfolio
Latest Institutional Activity in PDCO
Top Purchases
Top Sells
About PDCO
Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Insider Transactions at PDCO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Apr 17
2025
|
Pamela J Tomczik |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,820
-100.0%
|
-
|
Apr 17
2025
|
Philip Mc Koy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,114
-100.0%
|
-
|
Apr 17
2025
|
Neil A Schrimsher |
SELL
Sale (or disposition) back to the issuer
|
Direct |
48,788
-100.0%
|
-
|
Apr 17
2025
|
Robert Frenzel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
38,242
-100.0%
|
-
|
Apr 17
2025
|
Jody H Feragen |
SELL
Sale (or disposition) back to the issuer
|
Direct |
56,145
-100.0%
|
-
|
Apr 17
2025
|
John D Buck |
SELL
Sale (or disposition) back to the issuer
|
Direct |
92,869
-100.0%
|
-
|
Apr 17
2025
|
Alex N Blanco |
SELL
Sale (or disposition) back to the issuer
|
Direct |
41,300
-100.0%
|
-
|
Apr 17
2025
|
Meenu Agarwal |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,788
-100.0%
|
-
|
Apr 17
2025
|
Donald Zurbay President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,243
-100.0%
|
-
|
Apr 17
2025
|
Donald Zurbay President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
398,185
-100.0%
|
-
|
Apr 17
2025
|
Donald Zurbay President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
175,449
+14.53%
|
-
|
Apr 17
2025
|
Kevin M Pohlman Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,923
-100.0%
|
-
|
Apr 17
2025
|
Kevin M Pohlman Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
217,107
-100.0%
|
-
|
Apr 17
2025
|
Kevin M Pohlman Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,810
+9.11%
|
-
|
Apr 17
2025
|
Samantha L Bergeson CHRO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
998
-100.0%
|
-
|
Apr 17
2025
|
Samantha L Bergeson CHRO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,117
-100.0%
|
-
|
Apr 17
2025
|
Samantha L Bergeson CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
14,530
+18.88%
|
-
|
Apr 17
2025
|
Les B Korsh CLO & Corporate Secretary |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,283
-100.0%
|
-
|
Apr 17
2025
|
Les B Korsh CLO & Corporate Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
153,973
-100.0%
|
-
|
Apr 17
2025
|
Les B Korsh CLO & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
51,260
+11.1%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 615K shares |
---|
Sale (or disposition) back to the issuer | 1.21M shares |
---|---|
Payment of exercise price or tax liability | 26.9K shares |
Open market or private sale | 19.4K shares |